5-151886774-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PP3_ModeratePP5BS1_Supporting

The NM_000171.4(GLRA1):​c.199G>A​(p.Val67Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000334 in 1,612,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 0 hom. )

Consequence

GLRA1
NM_000171.4 missense

Scores

13
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2

Conservation

PhyloP100: 7.39

Publications

8 publications found
Variant links:
Genes affected
GLRA1 (HGNC:4326): (glycine receptor alpha 1) The protein encoded by this gene is a subunit of a pentameric inhibitory glycine receptor, which mediates postsynaptic inhibition in the central nervous system. Defects in this gene are a cause of startle disease (STHE), also known as hereditary hyperekplexia or congenital stiff-person syndrome. Multiple transcript variants encoding different isoforms have been found. [provided by RefSeq, Dec 2015]
GLRA1 Gene-Disease associations (from GenCC):
  • hyperekplexia 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.874
PP5
Variant 5-151886774-C-T is Pathogenic according to our data. Variant chr5-151886774-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 575744.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000349 (510/1460612) while in subpopulation NFE AF = 0.000444 (493/1110882). AF 95% confidence interval is 0.000411. There are 0 homozygotes in GnomAdExome4. There are 230 alleles in the male GnomAdExome4 subpopulation. Median coverage is 29. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000171.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLRA1
NM_000171.4
MANE Select
c.199G>Ap.Val67Met
missense
Exon 3 of 9NP_000162.2
GLRA1
NM_001292000.2
c.-51G>A
5_prime_UTR_premature_start_codon_gain
Exon 2 of 8NP_001278929.1
GLRA1
NM_001146040.2
c.199G>Ap.Val67Met
missense
Exon 3 of 9NP_001139512.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLRA1
ENST00000274576.9
TSL:1 MANE Select
c.199G>Ap.Val67Met
missense
Exon 3 of 9ENSP00000274576.5
GLRA1
ENST00000455880.2
TSL:1
c.199G>Ap.Val67Met
missense
Exon 3 of 9ENSP00000411593.2
GLRA1
ENST00000462581.6
TSL:1
n.71G>A
non_coding_transcript_exon
Exon 2 of 8ENSP00000430595.1

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000163
AC:
41
AN:
251238
AF XY:
0.000125
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000299
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000349
AC:
510
AN:
1460612
Hom.:
0
Cov.:
29
AF XY:
0.000316
AC XY:
230
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33446
American (AMR)
AF:
0.0000447
AC:
2
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.000444
AC:
493
AN:
1110882
Other (OTH)
AF:
0.000116
AC:
7
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41564
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000338
Hom.:
0
Bravo
AF:
0.000181
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.000273
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary hyperekplexia Pathogenic:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 67 of the GLRA1 protein (p.Val67Met). This variant is present in population databases (rs142888296, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of autosomal recessive hyperekplexia (PMID: 30182260; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 575744). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GLRA1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.

GLRA1-related disorder Uncertain:1
Nov 09, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The GLRA1 c.199G>A variant is predicted to result in the amino acid substitution p.Val67Met. This variant was reported in the compound heterozygous state in an individual with hyperekplexia. The father who carried this variant was unaffected and the mother carrying the second GLRA1 variant (loss of function) was affected by hyperekplexia with a less severe phenotype, suggesting that p.Val67Met may act as a hypomorphic allele only enhancing the phenotype (Milenkovic et al. 2018. PubMed ID: 30182260). This variant is reported in 0.029% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-151266335-C-T). Although we suspect this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

not provided Uncertain:1
Jul 15, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in an individual with hyperekplexia who inherited the variant from their unaffected father and harbored an additional GLRA1 variant in trans; the additional variant was inherited from a similarly affected mother (PMID: 30182260); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30182260)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
32
DANN
Uncertain
1.0
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.92
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.62
D
MetaRNN
Pathogenic
0.87
D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
7.4
PrimateAI
Pathogenic
0.88
D
PROVEAN
Uncertain
-2.6
D
REVEL
Pathogenic
0.87
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.84
MVP
0.90
MPC
2.1
ClinPred
0.69
D
GERP RS
5.5
Varity_R
0.85
gMVP
0.85
Mutation Taster
=32/68
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142888296; hg19: chr5-151266335; COSMIC: COSV51013952; API